{
    "eid": "2-s2.0-85168574489",
    "title": "Clinical Characteristics, Prognostic Factors and Overall Survival of Patients with Uterine Sarcoma at King Chulalongkorn Memorial Hospital during 2002-2019",
    "cover-date": "2023-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Obstetrics and Gynecology",
            "@code": "2729",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "disease-free survival",
        "overall survival",
        "prognostic factors",
        "uterine sarcoma"
    ],
    "authors": [
        "Rujira Manorompattarasarn",
        "Shina Oranratanaphan"
    ],
    "citedby-count": 0,
    "ref-count": 27,
    "ref-list": [
        "Uterine sarcomas: The Curie Institut Experience. Prognosis factors and adjuvant treatments",
        "Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients",
        "Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999",
        "Uterine sarcomas",
        "Uterineleiomyosarcoma: A review of the literature and update on management options",
        "Endometrial stromal sarcoma: An aggressive uterine malignancy",
        "Uterine carcinosarcoma",
        "Low-grade endometrial stromal sarcoma - a review",
        "Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy",
        "Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study",
        "Options for adjuvant therapy for uterine leiomyosarcoma",
        "Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)",
        "Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003)",
        "Role of lymphadenectomy for uterine sarcoma: a meta-analysis",
        "Uterine sarcomas at Ramathibodi Hospital (1969-1986)",
        "Undiagnosed uterine sarcomas identified during surgery for presumed leiomyoma at a national tertiary hospital in Thailand: A 10-year review",
        "New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)",
        "Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor",
        "The role of surgery and treatment trends in uterine sarcoma",
        "Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma",
        "Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007",
        "Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments",
        "Howtodifferentiateuterineleiomyosarcoma from leiomyoma with imaging",
        "Comparison of the diagnostic accuracy of contrast-enhanced/DWI MRI and ultrasonography in the differentiation between benign and malignant myometrial tumors",
        "The comparison of 1988 and 2009 FIGO staging system for uterine sarcoma in King Chulalongkorn Memorial Hospital during 1999-2008",
        "Prognostic factors associated with uterine sarcomas: the experience of a single institution"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": []
}